Investment
Features
FeesSafety
Academy
More
Pluang+

Pi Network risks dropping to $0.0705 as stablecoin integration may boost utility but not demand.

Technical Signals
14 Oct 2026
AMBCrypto
View Source
Neutral
Pi Network risks dropping to $0.0705 as stablecoin integration may boost utility but not demand.

Pi Network's token price has struggled to recover, recently falling below key support at $0.07685 and risking a drop to $0.0705. Despite a brief surge in August, selling pressure remains strong with weak market momentum. The upcoming stablecoin integration through a partnership with Open Standard could expand Pi's utility for payments and increase network activity, but it is uncertain if this will translate into higher demand or sustainable growth. Investors should watch for price movements around $0.07685 and $0.085 to gauge recovery potential.

Pi Network's token price situation is presented here with Pluang's market data as context. As of Oct 14, 2026 16:31 WIB, among 50 major cryptocurrencies on Pluang, 13 rose and 36 fell. Notable movers include CAKE at Rp42.684 with a 4.31% increase and 83% buy order activity, DOT at Rp20.361 with a 4.26% decrease and 64% sell order activity, and KSM at Rp82.978 with a 3.24% decrease and 90% sell order activity.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
59 minutes ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
1 hour ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
1 hour ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
1 hour ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App